Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,291 | -27,262 | -74,272 | -55,270 | -36,326 |
| Depreciation Amortization | 710 | 342 | 1,344 | 1,009 | 674 |
| Accounts receivable | N/A | N/A | 1,104 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,300 | -732 | 2,363 | 555 | 409 |
| Other Working Capital | -3,034 | -6,006 | 9,034 | 1,308 | -929 |
| Other Operating Activity | 13,065 | 6,578 | 8,220 | 8,566 | 5,918 |
| Operating Cash Flow | $-51,850 | $-27,080 | $-52,207 | $-43,832 | $-30,254 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -72,327 | -42,929 | -6,864 | -16,885 | -3,245 |
| PPE Investments | -1,231 | -297 | -929 | -864 | -645 |
| Investing Cash Flow | $-73,558 | $-43,226 | $-7,793 | $-17,749 | $-3,890 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 829 | 219 | 918 | 640 | 640 |
| Debt Repayment | -594 | -316 | -1,495 | -1,154 | -794 |
| Common Stock Issued | 129,727 | 128,496 | 57,353 | 53,137 | 52,994 |
| Financing Cash Flow | $129,962 | $128,399 | $56,776 | $52,623 | $52,840 |
| Beginning Cash Position | 44,503 | 44,503 | 47,727 | 47,727 | 47,727 |
| End Cash Position | 49,057 | 102,596 | 44,503 | 38,769 | 66,423 |
| Net Cash Flow | $4,554 | $58,093 | $-3,224 | $-8,958 | $18,696 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,850 | -27,080 | -52,207 | -43,832 | -30,254 |
| Capital Expenditure | -1,231 | -297 | -933 | -864 | -645 |
| Free Cash Flow | -53,081 | -27,377 | -53,140 | -44,696 | -30,899 |